17.03.2020

Spread of Covid-19 infection

Dear Clients!

Regarding the risks of the spread of the new coronavirus Covid-19 infection worldwide and its potential impact, Renesource Capital AS of IBS would like to affirm and inform that the provision of investment services and ancillary investment services will not be impeded.

Renesource Capital AS IBS has developed a comprehensive Business Continuity Plan, which is regularly updated and revised to reflect the latest trends and high regulatory requirements.

The aforementioned does not preclude an action plan for the Company's employees to perform their direct duties remotely in accordance with the Company's Business Continuity Plan, in the event of a global or large-scale epidemic or pandemic.

The Company will continue to closely follow the development of the situation, following the instructions and guidelines of the Ministry of Health of Republic of Latvia, Cabinet of Ministers of Republic of Latvia, Latvian Centre of Infectious Diseases and World Health Organization.

With this announcement we would like to affirm that we have taken all necessary preventive measures to ensure the full and uninterrupted operation of the Company in the case of various development scenarios.

Renesource Capital AS IBS office in Riga operates and serves clients on a regular basis - Monday to Friday, according to the Company's business hours.

In case of questions and uncertainties, you are welcome to contact your account manager.

Sincerely,
Renesource Capital AS IBS

Risk Disclosure Statement. Margin transactions (Forex, contracts for difference CFD, futures and futures options, stock options, REPO transactions, transactions in over-the-counter derivatives and transactions using broker credit, including selling short) involve higher risk. The level of risk increases with the leverage ratio. As the result of margin transactions, relatively high profits are possible with low level of initial investments, as well as significant losses which may exceed the principal amount of investments or the amount of the collateral. Please ascertain whether margin transactions in their essence and content suit the risk profile that was assigned to you by AS IBS Renesource Capital and whether the content of margin transactions corresponds to your investment goals.

We use cookies to provide you with a more convenient and safer user experience. By continuing the browsing session, you confirm that you agree to the use of cookies. You can revoke your consent at any time by changing your browser settings and deleting the cookies stored. Read our Cookie Policy.